These organoids, which retain the genetic, molecular, and phenotypic features of the original tumor, provide a robust ex vivo platform to assess the functional impact of USP5 depletion on ferroptosis susceptibility and tumor growth dynamics. Here, USP5 is linked to neoplasm.